Clinical trial
A Study to Determine How and Why HIV-Infected Subjects on Anti-viral Treatment…
NCT00006190 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00006190 |
|---|---|
| Title | A Study to Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop Lipodystrophy |
| Official title | The Study of Mechanisms of Lipodystrophy in HIV-Infected Patients |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections, Lipodystrophy |
| Intervention type | Drug |
| Interventions | Nelfinavir mesylate, Stavudine, Lamivudine, Efavirenz |
| Start date | Nov 1, 2000 |
| Completion | Nov 1, 2001 |
| First posted | Aug 28, 2000 |
| Last update posted | Mar 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: